Dr. Bartlett’s research interests include indoor air quality, bioaerosol exposures in work and community environments, particularly in rural or agricultural settings. Current research includes ; antifungal agents in vivo and in vitro, assessing bioaerosol exposures to compost workers from thermophilic organisms, pathogen loading of surface water impacted by agricultural land use, and microbial removal by slow sand filtration.
Relevant NGDI Articles
Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforest. Hagen F, Ceresini PC, Polacheck I, Ma H, van Nieuwerburgh F, Gabaldón T, Kagan S, Pursall ER, Hoogveld HL, van Iersel LJ, Klau GW, Kelk SM, Stougie L, Bartlett KH, Voelz K, Pryszcz LP, Castañeda E, Lazera M, Meyer W, Deforce D, Meis JF, May RC, Klaassen CH, Boekhout T. PLoS One. 2013 Aug 7;8(8):e71148.
Detection of Cryptococcus gattii in selected urban parks of the Willamette Valley, Oregon. Mortenson JA, Bartlett KH, Wilson RW, Lockhart SR. Mycopathologia. 2013 Apr;175(3-4):351-5.
Efficacy of an oral and tropically stable lipid-based formulation of Amphotericin B (iCo-010) in an experimental mouse model of systemic candidiasis. Ibrahim F, Sivak O, Wasan EK, Bartlett K, Wasan KM. Lipids Health Dis. 2013 Oct 29;12(1):158.
Phenotypic antibiotic resistance of Escherichia coli and E. coli O157 isolated from water, sediment and biofilms in an agricultural watershed in British Columbia. Maal-Bared R, Bartlett KH, Bowie WR, Hall ER. Sci Total Environ. 2013 Jan 15;443:315-23.
Efficacy and toxicity of a tropically stable lipid-based formulation of amphotericin B (iCo-010) in a rat model of invasive candidiasis. Ibrahim F, Gershkovich P, Sivak O, Wasan EK, Bartlett K, Wasan KM. Int J Pharm 2012 436(1-2):318-323.